# China Launches Nationwide HPV Vaccination Program for Girls to Combat Cervical Cancer
A new nationwide initiative aims to significantly reduce the incidence of cervical cancer by providing free HPV vaccinations to eligible girls across China.
On November 10, China formally integrated the human papillomavirus (HPV) vaccine into its National Immunization Program (NIP) for girls aged 13 and over.This landmark decision represents a major step forward in public health, offering a crucial preventative measure against one of the moast common cancers affecting women. Local health authorities will administer two doses of the bivalent HPV vaccine – spaced six months apart – to girls turning 13 years old on or after November 10, 2011.
Addressing a Significant Public Health Challenge
Table of Contents
Cervical cancer is a leading cause of malignancy in the female reproductive system, with persistent infection by high-risk types of HPV identified as the primary driver of the disease. The HPV vaccine functions by preventing initial infection and reducing the likelihood of persistent infections, effectively blocking the progress of precancerous lesions and ultimately preventing cervical cancer.
“This program is a critical investment in the health and well-being of future generations of women in China,” a senior official stated.
Optimal Vaccination Timing for Maximum Protection
Research indicates that younger recipients benefit most from the HPV vaccine. Studies show girls aged 9 to 14 generate antibody levels more than twice as high after vaccination compared to those aged 15 and above, with protection lasting for at least a decade. Consequently, vaccinating at age 13 is believed to provide stronger and more durable immune protection.
Eligibility and Registration Details
The program extends beyond Chinese citizens, with foreign nationals residing in Shanghai who meet the eligibility criteria also able to receive the vaccination at no cost. Individuals can register for the NIP HPV vaccine through the Jiankangyun (健康云) platform, also known as the Health Cloud platform.
The registration process, exemplified using the WeChat mini program, involves the following steps:
- Search for the Health Cloud mini program.
- tap “Wisdom Vaccination.”
- Select “Make an appointment to get vaccinated.”
- Link passport details.
- Choose the free bivalent HPV vaccine.
- Follow on-screen instructions to select a vaccination site and appointment time.
- Confirm the appointment upon submission of information.
Eligible girls must be accompanied by a guardian and present their vaccination records and valid identification, such as a passport, at the vaccination clinic.
This initiative underscores China’s commitment to proactive healthcare and preventative medicine,offering a powerful tool in the fight against cervical cancer and improving the health outcomes for women nationwide.
Why: China launched this program to combat the high incidence of cervical cancer, a leading cause of malignancy in women. The program aims to prevent HPV infections, the primary driver of the disease.
Who: The program targets girls aged 13 and over, including foreign nationals residing in Shanghai, and is administered by local health authorities. Guardians must accompany eligible girls.
What: The initiative provides free doses of the bivalent HPV vaccine, administered six months apart, through the National Immunization Program (NIP). Registration is done via the Jiankangyun (health Cloud) platform.
How did it end?: As of November 10, the program is ongoing. It began with the formal integration of the HPV vaccine into the NIP and continues through registration and vaccination appointments scheduled via the Health Cloud platform. The long-term impact will be measured by tracking cervical cancer rates
